Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
2014 · British Journal of Cancer · 40 citations
https://doi.org/10.1038/bjc.2014.494
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
430
Citations
8
h-index
7
i10-index
Li Cp is an academic researcher from Taizhou University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Marine Sponges and Natural Products & Synthesis and Biological Activity. The author has an h-index of 8, co-authored 29 publications.
https://doi.org/10.1038/bjc.2014.494
https://doi.org/10.1016/j.annonc.2024.08.1595
Click to start Chat